Literature DB >> 15982591

Is mitral valve surgery safe in octogenarians?

Jayan Nagendran1, Colleen Norris, Andrew Maitland, Arvind Koshal, David B Ross.   

Abstract

OBJECTIVE: To evaluate the outcomes of mitral valve surgery in octogenarians.
METHODS: Data were collected prospectively from January 1996 to March 2004 at two surgical centers. Of 1386 consecutive patients with mitral valve surgery, 58 (4.2%) were aged > or = 80 years. Survival data were analyzed using Cox proportional hazards modeling and Kaplan-Meier actuarial log rank statistics.
RESULTS: Octogenarians were similar to younger patients for the presence of pre-operative hypertension, hyperlipidemia, diabetes mellitus, and smoking history. Octogenarians had a higher incidence of cerebrovascular disease (19.0 versus 7.8%, P = 0.003), urgent in-hospital surgery (55.2 versus 28.6%, P < 0.001), and presence of ischemic disease requiring combined mitral valve plus revascularization surgery (72.4 versus 41.0%, P < 0.001). Mitral valve repair was performed in a similar proportion of octogenarians and younger patients (44.8 versus 45.6%). Thirty-day mortality for octogenarians was significantly higher than younger patients (15.5 versus 5.6%, P = 0.002), and actuarial survival of octogenarians was significantly decreased (P = 0.009). However, 52.3% of the octogenarians were alive at 7-years following surgery. Independent predictors of mortality from multivariate risk adjusted modeling of the entire cohort were: emergency surgery (hazards ratio [HR] = 2.94, P < 0.001), combined mitral valve plus revascularization surgery (HR = 2.27, P < 0.001), mitral valve replacement (HR = 1.85, P < 0.01), and age > or = 80 years (HR = 1.80, P = 0.02).
CONCLUSIONS: Octogenarians undergoing mitral valve surgery have significantly greater incidence of urgent surgery, ischemic disease requiring combined revascularization surgery, and have decreased rates of survival. While caution is required when operating on these higher risk elderly patients, overall 52.3% of the octogenarians are alive at 7-years following surgery, which is greater than the survival of octogenarians in the community. The greatest survival benefit within octogenarians occurred when mitral valve repair was possible over replacement. Further study will more clearly define subgroups of octogenarians with potentially greater benefit from mitral valve surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15982591     DOI: 10.1016/j.ejcts.2004.12.067

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Heart valve surgery in octogenarians: operative and long-term results.

Authors:  Shigeaki Aoyagi; Shuji Fukunaga; Koichi Arinaga; Hiroshi Tomoeda; Koji Akasu; Tomohiro Ueda
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

Review 2.  Long-term outcomes of mitral valve repair versus replacement for degenerative disease: a systematic review.

Authors:  Christian A McNeely; Christina M Vassileva
Journal:  Curr Cardiol Rev       Date:  2015

3.  Outcomes and Predictors of Mortality After Mitral Valve Surgery in High-Risk Elderly Patients: The Heidelberg Experience.

Authors:  Sabreen Mkalaluh; Marcin Szczechowicz; Bashar Dib; Gabor Szabo; Matthias Karck; Alexander Weymann
Journal:  Med Sci Monit       Date:  2017-12-31

4.  Concomitant ablation of atrial fibrillation in octogenarians: an observational study.

Authors:  Herko Grubitzsch; Sven Beholz; Pascal M Dohmen; Simon Dushe; Wolfgang Konertz
Journal:  J Cardiothorac Surg       Date:  2008-04-29       Impact factor: 1.637

5.  Association between older age and outcome after cardiac surgery: a population-based cohort study.

Authors:  Wei Wang; Sean M Bagshaw; Colleen M Norris; Rami Zibdawi; Mohamad Zibdawi; Roderick MacArthur
Journal:  J Cardiothorac Surg       Date:  2014-11-18       Impact factor: 1.637

6.  Predictors of survival in octogenarians after mitral valve surgery for degenerative disease: The Mitral Surgery in Octogenarians study.

Authors:  Pierpaolo Chivasso; Vito D Bruno; Shakil Farid; Pietro Giorgio Malvindi; Amit Modi; Umberto Benedetto; Franco Ciulli; Yasir Abu-Omar; Massimo Caputo; Gianni D Angelini; Steve Livesey; Hunaid A Vohra
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-20       Impact factor: 5.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.